Live Breaking News & Updates on Masanori Sasaki

Stay updated with breaking news from Masanori sasaki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Yale scientists repair injured spinal cords using patients' own stem cells


By Lakshmi Bangalore
February 22, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
(© stock.adobe.com)
Intravenous injection of bone marrow derived stem cells (MSCs) in patients with spinal cord injuries led to significant improvement in motor functions, researchers from Yale University and Japan report Feb. 18 in the Journal of Clinical Neurology and Neurosurgery.
For more than half of the patients, substantial improvements in key functions such as ability to walk, or to use their hands were observed within weeks of stem cell injection, the researchers report. No substantial side effects were reported.
The patients had sustained non-penetrating spinal cord injuries, in many cases from falls or minor trauma, several weeks prior to implantation of the stem cells. Their symptoms involved loss of motor function and coordination, sensory loss, as well as bowel and bladder dysfunction. The stem cel ....

Stepheng Waxman , Masanori Sasaki , Osamu Honmou , Jefferyd Kocsis , Yale University , Sapporo Medical University , Clinical Neurology , யேல் பல்கலைக்கழகம் , சப்போரோ மருத்துவ பல்கலைக்கழகம் , மருத்துவ நரம்பியல் ,

Scientists repair spinal cord injuries using patients' stem cells


Scientists repair spinal cord injuries using patients’ stem cells
11
In a Phase II trial, all 13 patients who received an intravenous infusion of their own mesenchymal stem cells had improvements in neurological function six months later.
In a new study, investigators demonstrated the feasibility, safety and efficacy of using a single intravenous infusion of mesenchymal stem cells (MSCs) to treat spinal cord injury (SCI) patients. According to the researchers, more than half of patients had substantial improvements in key functions, such as walking and using their hands, within weeks of the treatment.
In the Phase II trial, 13 patients who had sustained non-penetrating SCI received an intravenous infusion of autologous (their own) MSCs cultured in auto-serum under Good Manufacturing Practice (GMP) production. The participants were then observed to see if their SCI symptoms – such as loss of motor function and coordination, sensory loss and bowel and bladder dys ....

United States , Masanori Sasaki , Jeffery Kocsis , Osamu Honmou , Stephen Waxman , Yale University , American Spinal Injury Association Impairment Scale , International Standards For Neurological , Sapporo Medical University , Good Manufacturing Practice , International Standards , Functional Classification , Spinal Cord , Spinal Cord Independence Measure , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்பரி கோசிஸ் , ஸ்டீபன் மெழுகு , யேல் பல்கலைக்கழகம் , அமெரிக்கன் முதுகெலும்பு காயம் சங்கம் குறைபாடு அளவு , சர்வதேச தரநிலைகள் க்கு நரம்பியல் , சப்போரோ மருத்துவ பல்கலைக்கழகம் , நல்ல உற்பத்தி ப்ர்யாக்டீஸ் , சர்வதேச தரநிலைகள் , செயல்பாட்டு வகைப்பாடு , முதுகெலும்பு தண்டு , முதுகெலும்பு தண்டு சுதந்திரம் அளவீட்டு ,